International Publications Archive - Seite 113 von 223 - IOZK

A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer

2012-01-01/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-01 / J Immunother 2012 Jan;35(1):54-65

[Prostate carcinoma: vaccination as a new option for treatment]

2012-01-01/in Dendritic Cells, International Publications, Prostate Cancer /von 2012-01-01 / Urologe A 2012 Jan;51(1):44-9

Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation

2012-01-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2012-01-01 / Methods Mol. Biol. 2012;797:177-204

The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma

2012-01-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-01-01 / Curr. Top. Microbiol. Immunol. 2012;351:181-220

Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report

2011-12-06/in Dendritic Cells, International Publications, NSCLC /von 2011-12-06 / Arch. Immunol. Ther. Exp. (Warsz.) 2012 Feb;60(1):69-77

Immunotherapy for glioma: getting closer to the clinical arena?

2011-12-01/in Dendritic Cells, Glioblastoma, International Publications /von 2011-12-01 / Curr. Opin. Neurol. 2011 Dec;24(6):641-7

The roles of tumor-derived exosomes in cancer pathogenesis

2011-11-30/in Exosome, International Publications /von 2011-11-30 / Clin. Dev. Immunol. 2011;2011:842849

Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo

2011-11-30/in Acute Leukemia, International Publications, Newcastle Disease Virus /von 2011-11-30 / Leuk. Res. 2012 May;36(5):634-45

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

2011-11-26/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-11-26 / Vaccine 2012 Jun;30(29):4394-7

Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells

2011-11-23/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-23 / Int. J. Oncol. 2012 Mar;40(3):764-72